Essays Tagged: "ImClone Systems"

Martha steps down This paper discusses Martha Stewart's decision to step down as CEO and the ecomonic repercussions of the in-sider trading allegations.

or securities fraud and lying to federal investigators after she sold shares in the biotech company ImClone Systems Inc before the price fell.Martha recently stepped down as chairman and CEO in hopes ...

(1 pages) 175 0 2.5 Dec/2003

Subjects: Social Science Essays > Economics

Management paper

oping cures for cancer that include Amgen, Affymax, Onyvax , Angiotech Pharmaceuticals, Antigenics, ImClone Systems, etc. The indirect competition includes the bigger players in the industry such as G ... mpany may choose. Companies such as Amgen, Affymax, Onyvax , Angiotech Pharmaceuticals, Antigenics, ImClone Systems, and EntreMed discover and develop peptide drugs to treat cancer and immune-mediated ...

(13 pages) 486 1 5.0 Apr/2004

Subjects: Businesss Research Papers > Management

The case against Martha Stewart surrounded her sale of shares in ImClone Systems Inc., Had she acted responsibly?

The case against Martha Stewart surrounded her sale of 3,928 shares in ImClone Systems Inc., and whether she lied to investigators and her company's investors about it. On ... ied to investigators and her company's investors about it. On Dec. 27, 2001, Stewart cashed out her ImClone stake at an average price of $58.43, collecting about $229,500. After the market closed the ... e market closed the following day, the Food and Drug Administration announced its refusal to review ImClone's application for Erbitux, a promising cancer drug. The next trading day, Dec. 31, ImClone's ...

(6 pages) 121 0 0.0 Feb/2006

Subjects: Businesss Research Papers > Case Studies

Imclone Systems

Late in the afternoon of December 28, 2001, the fax machine at the SoHo offices of ImClone Systems, spit out a stunning announcement. Citing sloppy data and poor research design, the ... to come. In March 2003, after an excruciatingly painful effort to put the company's house in order, ImClone's officers took yet another devastating call from the Feds. Improper accounting for taxes on ... ould be on the hook for taxes of $60 million, before penalties and interest. What's more, in April, ImClone was warned by Nasdaq that its stock could be de-listed if its 10-K wasn't filed by June 23, ...

(3 pages) 30 0 3.0 Jul/2006

Subjects: Businesss Research Papers > Case Studies

Martha Stewart's insider trading scandal as a case study for Business Ethics

f a responsible CEO.The scandal can be surmised that Martha sold 3,928 shares of biotech drug maker ImClone Systems Inc. on Dec. 27, 2001 - after an inside trader tip-off that Food and Drug Administra ... n Dec. 27, 2001 - after an inside trader tip-off that Food and Drug Administration would not review ImClone's application for approval of Erbitux, which the company had touted as a promising cancer dr ...

(4 pages) 64 0 5.0 Oct/2009

Subjects: Businesss Research Papers > Case Studies